ARTICLE | Clinical News
KO-947: Ph I started
April 19, 2017 9:51 PM UTC
Kura began an open-label, dose-escalation, U.S. Phase I trial to evaluate IV KO-947 in about 72 patients....
BCIQ Company Profiles
Kura began an open-label, dose-escalation, U.S. Phase I trial to evaluate IV KO-947 in about 72 patients....
BCIQ Company Profiles
BCIQ Company Profiles